Silo Pharma, Inc. (SILO)
NASDAQ: SILO · IEX Real-Time Price · USD
2.430
-0.030 (-1.22%)
Jul 22, 2024, 10:17 AM EDT - Market open
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,198,651
Market Cap
9.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zhongchao | 142 |
| PAVmed | 107 |
| Molecular Templates | 62 |
| Elevai Labs | 18 |
| NLS Pharmaceutics AG | 7 |
| Nexalin Technology | 6 |
| Mangoceuticals | 3 |
| Cyclerion Therapeutics | 1 |
SILO News
- 3 days ago - Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 days ago - Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug - Benzinga
- 4 days ago - Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15 - GlobeNewsWire
- 5 days ago - Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday? - Benzinga
- 6 days ago - Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic - GlobeNewsWire
- 26 days ago - Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety - GlobeNewsWire
- 6 weeks ago - Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia - GlobeNewsWire
- 6 weeks ago - Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire